In the present study, treatment with gasdermin inhibitor disulfiram reduced aneurysmal aortic diameter enlargement, lowered AAA incidence, and ameliorated aneurysm severity in ApoE deficient mice following Ang II infusion. Here, GSDMA is linked to triple-A syndrome.